J. Coves Sarto

647 total citations
5 papers, 36 citations indexed

About

J. Coves Sarto is a scholar working on Pulmonary and Respiratory Medicine, Oncology and Surgery. According to data from OpenAlex, J. Coves Sarto has authored 5 papers receiving a total of 36 indexed citations (citations by other indexed papers that have themselves been cited), including 3 papers in Pulmonary and Respiratory Medicine, 3 papers in Oncology and 1 paper in Surgery. Recurrent topics in J. Coves Sarto's work include PARP inhibition in cancer therapy (2 papers), Congenital Anomalies and Fetal Surgery (1 paper) and Colorectal Cancer Treatments and Studies (1 paper). J. Coves Sarto is often cited by papers focused on PARP inhibition in cancer therapy (2 papers), Congenital Anomalies and Fetal Surgery (1 paper) and Colorectal Cancer Treatments and Studies (1 paper). J. Coves Sarto collaborates with scholars based in Spain, France and United States. J. Coves Sarto's co-authors include Santiago Viteri, Matthew V. Lorenzi, Melissa L. Johnson, Arun Rajan, Mark Wade, Ana Laura Ortega Granados, M. Dómine Gómez, Ravi Salgia, Mark M. Awad and Nibedita Bandyopadhyay and has published in prestigious journals such as Annals of Oncology, Journal of Thoracic Oncology and JTO Clinical and Research Reports.

In The Last Decade

J. Coves Sarto

5 papers receiving 36 citations

Peers

Countries citing papers authored by J. Coves Sarto

Since Specialization

Citations

This map shows the geographic impact of J. Coves Sarto's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by J. Coves Sarto with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites J. Coves Sarto more than expected).

Fields of papers citing papers by J. Coves Sarto

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by J. Coves Sarto. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by J. Coves Sarto. The network helps show where J. Coves Sarto may publish in the future.

Co-authorship network of co-authors of J. Coves Sarto

This figure shows the co-authorship network connecting the top 25 collaborators of J. Coves Sarto. A scholar is included among the top collaborators of J. Coves Sarto based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with J. Coves Sarto. J. Coves Sarto is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

5 of 5 papers shown

#	Work	Indexed citations
1	160P Pembrolizumab re-challenge in patients with relapsed non-small cell lung cancer (NSCLC): A preliminary report of the REPLAY phase II trial - cohort I 2021 ·Annals of Oncology ·Santiago Ponce Aix, Enric Carcereny, Joaquim Bosch‐Barrera, E. Felip Font, M. Guirado, J. Coves Sarto, M. Majem Tarruella, Óscar Juan, E. Dalmau, Pilar Díz, Ana Laura Ortega Granados, M. Dómine Gómez, Ana Blasco, Joaquín Mosquera, (unknown), Miriam Leandro Dorta, Virginia Calvo, Jon Zugazagoitia, Ana B. Enguita, Luis Paz‐Ares	5
2	100MO Olaparib maintenance vs placebo in platinum-sensitive non-small cell lung cancer: The phase II randomized PIPSeN trial 2021 ·Journal of Thoracic Oncology ·Sophie Postel‐Vinay, David Planchard, (unknown), J. Coves Sarto, M. Dómine Gómez, (unknown), (unknown), Santiago Viteri, (unknown), Matthieu Texier, Ana Laura Ortega Granados, (unknown), (unknown), Ana López, Mariano Provencio, (unknown), J.C. Soria, Benjamin Besse, B. Massuti Sureda, Rafael Rosell	6
3	JNJ-64041757 (JNJ-757), a Live, Attenuated, Double-Deleted Listeria monocytogenes–Based Immunotherapy in Patients With NSCLC: Results From Two Phase 1 Studies 2020 ·JTO Clinical and Research Reports ·Julie R. Brahmer, Melissa L. Johnson, Manuel Cobo, Santiago Viteri, J. Coves Sarto, Ammar Sukari, Mark M. Awad, Ravi Salgia, Vali A. Papadimitrakopoulou, Arun Rajan, Nibedita Bandyopadhyay, Alicia J. Allred, Mark Wade, Gary Mason, Enrique Zudaire, Roland E. Knoblauch, Nicole L. Stone, Matthew V. Lorenzi, Raffit Hassan	23
4	A randomized double-blind phase II trial evaluating maintenance PARP inhibitor Olaparib versus placebo in patients with platinum-sensitive advanced non-small cell lung cancer: PIPSeN trial 2017 ·Annals of Oncology ·Sophie Postel‐Vinay, David Planchard, Ana Laura Ortega Granados, Anas Gazzah, (unknown), Margarita Majem, (unknown), (unknown), Jean‐Pierre Pignon, J. Cadranel, Jaafar Bennouna, Fabrice Barlési, (unknown), Santiago Viteri, Benjamin Besse, J. Coves Sarto, B. Massuti Sureda, J.C. Soria, Rafael Rosell	1
5	[Bile peritonitis caused by idiopathic perforation of a choledochal cyst]. 1986 ·PubMed ·(unknown), (unknown), F.A. Moraga Llop, J. Coves Sarto, (unknown), Juan B. Ochoa, Goya Enríquez	1

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact